<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04553783</url>
  </required_header>
  <id_info>
    <org_study_id>KC20OISI0022</org_study_id>
    <nct_id>NCT04553783</nct_id>
  </id_info>
  <brief_title>Exploration of Blood Biomarkers, Including Whole Blood Viscosity as a Prognostic Factor for Acute Pancreatitis</brief_title>
  <official_title>Exploration of Blood Biomarkers, Including Whole Blood Viscosity as a Prognostic Factor for Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>In Seok Lee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the usefulness of blood viscosity as a prognostic factor in&#xD;
      patients with acute pancreatitis. The study design is a single-arm prospective cohort&#xD;
      observational study. Blood biomarkers including blood viscosity, C-reactive protein,&#xD;
      hematocrit, and phosphate are measured and the correlation with the severity of acute&#xD;
      pancreatitis will be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several scoring systems are used to evaluate the prognosis of acute pancreatitis, but they&#xD;
      are rather complicated and clinically less useful. Blood viscosity is associated with&#xD;
      hematocrit and inflammatory factors known to be related to the prognosis of acute&#xD;
      pancreatitis, and our group's previous study which is not yet published showed that blood&#xD;
      viscosity better predicts severe acute pancreatitis than other single factors such as&#xD;
      C-reative protein. Therefore, this study aims to prospectively evaluate the usefulness of&#xD;
      blood viscosity as a prognostic factor for acute pancreatitis. During the study period, the&#xD;
      study is conducted on patients with acute pancreatitis between the ages of 19 and 70, and&#xD;
      patients with acute pancreatitis after ERCP are excluded. Blood viscosities at initial and 24&#xD;
      hours after hospitalization, and serum phosphate, which have shown potential as a predictor&#xD;
      of severity in post-ERCP pancreatitis in previous studies are measured. The association of&#xD;
      these blood biomarkers with the severity of acute pancreatitis will be analyzed and compared&#xD;
      with hematocrit, C-reactive protein, etc., which are known as a single prognostic predictor&#xD;
      of acute pancreatitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2020</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prediction of severity of acute pancreatitis using initial blood viscosity</measure>
    <time_frame>48hours after admission</time_frame>
    <description>Evaluate initial blood viscosity as a predictor of the severity of acute pancreatitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prediction of severity of acute pancreatitis using blood viscosity change after 24hours</measure>
    <time_frame>24hours after admission</time_frame>
    <description>Prediction of severity of acute pancreatitis using blood viscosity change after 24hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of severity of acute pancreatitis using serum phosphate</measure>
    <time_frame>48hours after admission</time_frame>
    <description>Prediction of severity of acute pancreatitis using serum phosphate</description>
  </secondary_outcome>
  <enrollment type="Anticipated">137</enrollment>
  <condition>Acute Pancreatitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients between 19 and 70 years of age with acute pancreatitis, excluding post-ERCP&#xD;
        pancreatitis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 19-70 years old&#xD;
&#xD;
          -  Acute pancreatitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Post-Endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>In Seok Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Hoon Choi, MD, MS</last_name>
    <phone>82-2-2258-6020</phone>
    <email>crzyzs@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>In Seok Lee, MD, PhD</last_name>
    <phone>82-2-2258-6022</phone>
    <email>isle@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St. Mary's hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Hoon Choi, MD, MS</last_name>
      <phone>82-2-2258-6020</phone>
      <email>crzyzs@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 3, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>In Seok Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

